| Title |
Publication Date |
Price |
Relevance |
Indian Pharmaceutical Industry, The:
|
March 2005 |
£3335 |
100 % |
Indian Pharmaceutical Industry
|
July 2008 |
£2075 |
100 % |
Indian Bioinformatics Industry
|
April 2004 |
£550 |
35 % |
Industry Insight Clinical Trials in India 2007
|
May 2007 |
£400 |
31 % |
Indian Bulk Drug Industry Insight 2007
|
May 2007 |
£400 |
30.45 % |
Indian Generics, 2008-2012
A Growing Threat to Westernised Markets
|
January 2008 |
£1600 |
28.35 % |
Indian Pharmaceutical Market, 2006-2011
|
June 2006 |
£1499 |
26.95 % |
India Pharmaceuticals and Healthcare Report Q3 2008
|
July 2008 |
£425 |
26.25 % |
Indian Healthcare Services Industry Report
|
January 2007 |
£400 |
26 % |
Latin American Market for Generic Drugs; The
|
April 2006 |
£995 |
25.2 % |
India Pharmaceuticals and Healthcare Report Q1 2009
|
February 2009 |
£250 |
24.15 % |
Comparison of Pharma Outsourcing between China and India
|
July 2009 |
£915 |
24.15 % |
Pharmaceutical Markets in India
|
April 2004 |
£790 |
23.5 % |
Guide to Pharmaceutical Outsourcing in China
|
February 2008 |
£600 |
23.45 % |
Japan Pharmaceuticals and Healthcare Report Q3 2008
|
September 2008 |
£425 |
23.45 % |
India: Pharmaceutical and biotechnology opportunities
|
April 2006 |
£840 |
22.75 % |
The Indian Pharmaceutical Market to 2011
Competitive dynamics and major players
|
July 2007 |
£1495 |
22.75 % |
Nigeria Pharmaceuticals and Healthcare Report Q4 2008
|
November 2008 |
£250 |
22.4 % |
Indian Biopharmaceuticals
|
January 2008 |
£600 |
22.05 % |
Contract Research and Manufacturing Services
India (CRAMS)
|
March 2008 |
£600 |
21.7 % |
Indian Medical Market Report
2005
|
May 2005 |
£675 |
20.3 % |
Japan Pharmaceuticals and Healthcare Report Q1 2009
|
March 2009 |
£250 |
19.95 % |
Indian Biopharmaceuticals Industry Report
|
January 2007 |
£400 |
19.6 % |
Achieving success in the Developing Asian Pharmaceutical Sector 2007-2011
|
November 2006 |
£1999 |
18.9 % |
India Pharmaceutical Regulatory Report 2009
|
January 2009 |
£1020 |
18.55 % |
Global Generics Industry Report
|
September 2006 |
£550 |
18.55 % |
Johnson & Johnson Healthcare - Medical Equipment SWOT Report
|
August 2008 |
£76 |
17.15 % |
Contract Manufacturing Strategies
Market developments, technology transfer and key success factors
|
May 2008 |
£1995 |
17.15 % |
Asia Generic Pharmaceuticals Forecast Report; The
|
July 2006 |
£510 |
17.15 % |
Booming Clinical Trials Market in India
|
November 2007 |
£730 |
17 % |
Booming Biotech Market in India
|
June 2008 |
£430 |
16.8 % |
Zimbabwe Pharmaceuticals and Healthcare Report Q3 2008
|
September 2008 |
£425 |
16.5 % |
Healthcare and Pharmaceuticals in Latin America
A guide to the markets and regulations
|
May 2005 |
£525 |
16.45 % |
Global. Generics
|
April 2009 |
£800 |
16.45 % |
Kazakhstan Pharmaceuticals and Healthcare Report Q2 2009
|
May 2009 |
£250 |
16 % |
The Indian Pharmaceutical Market Analysis and Forecasts 2008-2023
|
May 2008 |
£1499 |
15.05 % |
Pharmaceutical Regulatory Affairs in The Eu & US
|
January 2006 |
£1095 |
15 % |
The Pharmaceutical Market: Argentina
|
December 2008 |
£595 |
15 % |
World Market for Prescription Generic Drugs
6th Edition
|
April 2008 |
£2435 |
14.7 % |
Outsourcing Clinical Trials
A Global Analytical Guide and Comparative Analysis of International Destinations, with Location Attractiveness Index
|
May 2007 |
£1830 |
14.35 % |
Contract Pharma 2008-2023
|
August 2008 |
£1499 |
12.6 % |
Generic Option; The
|
July 2006 |
£440 |
12.6 % |
Dr. Reddy's Market Outlook, Forecasts and Analysis to 2012
|
April 2007 |
£1499 |
12.6 % |
The Outlook for Pharmaceuticals in Central Asia
|
March 2007 |
£1995 |
12 % |
Clinical Trials Market 2006, The
|
February 2006 |
£1499 |
11.9 % |
Indian Healthcare - New Avenues for Growth
|
October 2008 |
£490 |
11.9 % |
Bioinformatics Report
The forecasts and future of the market 2006-2011
|
October 2006 |
£1499 |
11.9 % |
M&A trends in Pharma
|
October 2008 |
£6000 |
11.55 % |
Veterinary Health Markets
|
December 2008 |
£2075 |
10.85 % |
Key Players in Pharmaceutical Contract Manufacturing
Market developments, outsourcing hotspots and growth strategies
|
March 2009 |
£2025 |
10.85 % |
Ophthalmic Pharmaceuticals, Market Analysis, Forecasts and Dynamics
2009-2023
|
January 2009 |
£1499 |
10.85 % |
The Pharmaceutical Industry 2008
Current and Future Trends and Strategic Issues Shaping Pharma
|
March 2008 |
£3010 |
10.85 % |
Bahrain Pharmaceuticals and Healthcare Report Q3 2008
|
September 2008 |
£425 |
10.5 % |
World Generics Market 2006-2011; The
|
May 2006 |
£1499 |
10.5 % |
World Generics Market, 2008-2013
|
November 2008 |
£1499 |
9.1 % |
China Pharma Outsourcing Market By 2015
|
January 2009 |
£1065 |
8.75 % |
Outsourcing in Drug Discovery, 3rd Edition
|
May 2008 |
£1825 |
8.05 % |
Clinical Trials Business; The
|
August 2006 |
£2960 |
7.7 % |
Biosimilars and Follow-On Biologics Report
The Global Outlook 2009-2024
|
April 2009 |
£1499 |
7.7 % |
Global Vaccines Market 2008-2023, The
|
August 2008 |
£1499 |
6.3 % |
World Generic Market Report 2007
|
November 2006 |
£595 |
5.95 % |
Incremental Improvements And Paradigm Shifts In Strategy Are Both Necessary To Boost Productivity
R&D Strategies
|
August 2007 |
£7600 |
5.25 % |
Animal Biotechnology
Technologies, Markets and Companies
|
May 2009 |
£1525 |
5.25 % |
World Generic Market Report 2009
|
January 2009 |
£595 |
4.55 % |
The Global Market for Advanced Wound Care Products 2007
|
May 2009 |
£795 |
4.2 % |
